Disparities in Biomarkers for Patients With Diabetes After the Affordable Care Act

Authors

Miguel Marino, OHSU-PSU School of Public HealthFollow
Heather Angier, Oregon Health & Science University
Katie Fankhauser, OHSU-PSU School of Public Health
Steele Valenzuela, Oregon Health & Science University
Megan Hoopes, OCHIN, Inc.
John Heintzman, Oregon Health & Science University
Jennifer E. DeVoe, Oregon Health & Science UniversityFollow
Laura Moreno, University of California - Berkeley
Nathalie Huguet, Portland State UniversityFollow

Published In

Medical Care

Document Type

Citation

Publication Date

7-2020

Abstract

Background: Racial and ethnic minorities are disproportionately affected by diabetes and at greater risk of experiencing poor diabetesrelated outcomes compared with non-Hispanic whites. The Affordable Care Act (ACA) was implemented to increase health insurance coverage and reduce health disparities. Objective: Assess changes in diabetes-associated biomarkers [hemoglobin A1c (HbA1c) and low-density lipoprotein] 24 months pre-ACA to 24 months post-ACA Medicaid expansion by race/ethnicity and insurance group. Research Design: Retrospective cohort study of community health center (CHC) patients. Subjects: Patients aged 19–64 with diabetes living in 1 of 10 Medicaid expansion states with ≥1 CHC visit and ≥1 HbA1c measurement in both the pre-ACA and the post-ACA time periods (N=13,342)

Description

Copyright (2020) Lippincott, Williams & Wilkins

Locate the Document

http://doi.org/10.1097/mlr.0000000000001257

DOI

10.1097/mlr.0000000000001257

Persistent Identifier

https://archives.pdx.edu/ds/psu/33034

Citation Details

Marino, M., Angier, H., Fankhauser, K., Valenzuela, S., Hoopes, M., Heintzman, J., ... & Huguet, N. (2020). Disparities in Biomarkers for Patients With Diabetes After the Affordable Care Act. Medical Care, 58, S31-S39.